XORTX Therapeutics (XRTX) Amortization - Intangibles (2021 - 2026)

XORTX Therapeutics' (XRTX) quarterly Amortization - Intangibles came in at $3460.0 in Q1 2026, down 47.4% on a QoQ basis from $6578.0 in Q4 2025.

XORTX Therapeutics (XRTX) Amortization - Intangibles (2021 - 2026) Analysis & Trends

XORTX Therapeutics (XRTX) has 6 years of Amortization - Intangibles data on file, last reported at $3460.0 in Q1 2026.

Quarterly Amortization - Intangibles changed N/A year-over-year to $3460.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23166.0 (changed N/A YoY) and the FY2025 annual result came in at $26385.0, down 15.08% from the prior year.
Amortization - Intangibles fell to $3460.0 in Q1 2026, from $6578.0 in the prior quarter.
In the past five years, Amortization - Intangibles ranged from a high of $49446.5 in Q1 2023 to a low of -$66802.3 in Q4 2023.
A 5-year average of $6256.8 and a median of $6604.5 in 2024 frame the typical range for Amortization - Intangibles.
Annual changes were most pronounced in 2023 — Amortization - Intangibles slumped 520.93% — and 2024, when it jumped 560.0%.
Tracing XRTX's Amortization - Intangibles over 5 years: stood at $15870.1 in 2022, then slumped by 520.93% to -$66802.3 in 2023, then surged by 109.93% to $6631.0 in 2024, then declined by 0.8% to $6578.0 in 2025, then slumped by 47.4% to $3460.0 in 2026.
The last three Amortization - Intangibles figures came in at $3460.0 (Q1 2026), $6578.0 (Q4 2025), and $6497.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	XORTX Therapeutics	2.84 Mn	2.84 Mn	-

Download Data